SHAREHOLDER ALERT: Kaskela Law LLC Announces Class Action Lawsuit Against Mednax, Inc. and Encourages Investors to Contact the Firm - MD

RADNOR, PA / ACCESSWIRE / September 8, 2018 / Kaskela Law LLC announces that a class action lawsuit has been filed against Mednax, Inc. (NYSE: MD) ("Mednax" or the "Company") on behalf of purchasers of the Company's securities between February 4, 2016 and July 27, 2017, inclusive (the "Class Period").

Mednax stockholders who would like more information about their rights and potential remedies are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (888) 715 – 1740 or [email protected]. Stockholders may also submit their information to the firm online at http://kaskelalaw.com/case/mednax/.

Mednax is a healthcare administration business that acquires and administers physician practice groups. During the Class Period, Mednax's business model depended upon growth from the acquisition of new practice groups, primarily in anesthesiology.

The class action complaint alleges that defendants made false and misleading statements and/or failed to disclose to investors during the Class Period that the Company's business model relied on the practice of acquiring anesthesiology practice groups and then suppressing physician compensation expenses. The complaint further alleges that Mednax's practice of underpaying anesthesiologists hindered its ability to retain these physicians once their post-acquisition contracts expired, which led Mednax to threaten enforcement of highly restrictive non-compete agreements that would cause many physicians to unwillingly renew their agreements.

On July 28, 2017, Mednax disclosed, during its second-quarter earnings call with investors and analysts, that the Company had failed to complete any acquisitions of anesthesiologist practices during the reporting quarter. Significantly, the Company also disclosed that future anesthesiologist acquisitions were unlikely, which it attributed to the "challenging" payor mix combined with "continued… growth in compensation expense for nurse anesthetists."

IMPORTANT DEADLINE: Investors who purchased Mednax's securities during the Class Period may, no later than September 10, 2018, seek to be appointed as a lead plaintiff representative of the class.

Mednax stockholders who would like more information about their rights and potential remedies are encouraged to contact Kaskela Law LLC. Kaskela Law LLC exclusively represents investors in state and federal courts throughout the country. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
201 King of Prussia Road
Suite 650
Radnor, PA 19087
(484) 258 – 1585
(888) 715 – 1740
[email protected]
www.kaskelalaw.com

SOURCE: Kaskela Law LLC

https://www.accesswire.com/511567/SHAREHOLDER-ALERT-Kaskela-Law-LLC-Announces-Class-Action-Lawsuit-Against-Mednax-Inc-and-Encourages-Investors-to-Contact-the-Firm-MD